These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antimicrobial activity of SM-17466, a novel carbapenem antibiotic with potent activity against methicillin-resistant Staphylococcus aureus. Sumita Y; Nouda H; Kanazawa K; Fukasawa M Antimicrob Agents Chemother; 1995 Apr; 39(4):910-6. PubMed ID: 7785994 [TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo antistaphylococcal activities of L-695,256, a carbapenem with high affinity for the penicillin-binding protein PBP 2a. Chambers HF Antimicrob Agents Chemother; 1995 Feb; 39(2):462-6. PubMed ID: 7726516 [TBL] [Abstract][Full Text] [Related]
4. Novel dithiocarbamate carbapenems with anti-MRSA activity. Ohtake N; Imamura H; Jona H; Kiyonaga H; Shimizu A; Moriya M; Sato H; Nakano M; Ushijima R; Nakagawa S Bioorg Med Chem; 1998 Jul; 6(7):1089-101. PubMed ID: 9730246 [TBL] [Abstract][Full Text] [Related]
6. Antibacterial activity of meropenem against gram-negative bacteria with a permeability defect and against staphylococci. Kitzis MD; Acar JF; Gutmann L J Antimicrob Chemother; 1989 Sep; 24 Suppl A():125-32. PubMed ID: 2808204 [TBL] [Abstract][Full Text] [Related]
7. Activity of meropenem, against gram-positive bacteria. Kayser FH; Morenzoni G; Strässle A; Hadorn K J Antimicrob Chemother; 1989 Sep; 24 Suppl A():101-12. PubMed ID: 2808202 [TBL] [Abstract][Full Text] [Related]
8. [Combination effect between panipenem and vancomycin on highly methicillin-resistant Staphylococcus aureus]. Fukuoka T; Domon H; Kakuta M; Ishii C; Hirasawa A; Utsui Y; Ohya S; Yasuda H Jpn J Antibiot; 1997 Apr; 50(4):411-9. PubMed ID: 9192249 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and activity of 2-(sulfonamido)methyl-carbapenems: discovery of a novel, anti-MRSA 1,8-naphthosultam pharmacophore. Wilkening RR; Ratcliffe RW; Wildonger KJ; Cama LD; Dykstra KD; DiNinno FP; Blizzard TA; Hammond ML; Heck JV; Dorso KL; St Rose E; Kohler J; Hammond GG Bioorg Med Chem Lett; 1999 Mar; 9(5):673-8. PubMed ID: 10201827 [TBL] [Abstract][Full Text] [Related]
10. In vitro activities of ME1036 (CP5609), a novel parenteral carbapenem, against methicillin-resistant staphylococci. Kurazono M; Ida T; Yamada K; Hirai Y; Maruyama T; Shitara E; Yonezawa M Antimicrob Agents Chemother; 2004 Aug; 48(8):2831-7. PubMed ID: 15273088 [TBL] [Abstract][Full Text] [Related]
11. Beta-lactam resistance mechanisms of methicillin-resistant Staphylococcus aureus. Franciolli M; Bille J; Glauser MP; Moreillon P J Infect Dis; 1991 Mar; 163(3):514-23. PubMed ID: 1995724 [TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships of carbapenem compounds to anti-Haemophilus influenzae activity and affinity for penicillin-binding proteins. Effect of 1 beta-methyl group and C-2 side chain. Kanazawa K; Nouda H; Sunagawa M J Antibiot (Tokyo); 1997 Feb; 50(2):162-8. PubMed ID: 9099227 [TBL] [Abstract][Full Text] [Related]
13. Recruitment of the mecA gene homologue of Staphylococcus sciuri into a resistance determinant and expression of the resistant phenotype in Staphylococcus aureus. Wu SW; de Lencastre H; Tomasz A J Bacteriol; 2001 Apr; 183(8):2417-24. PubMed ID: 11274099 [TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo antibacterial activities of CS-834, a new oral carbapenem. Sakagawa E; Otsuki M; Oh T; Nishino T J Antimicrob Chemother; 1998 Oct; 42(4):427-37. PubMed ID: 9818740 [TBL] [Abstract][Full Text] [Related]
15. Structural basis for the beta lactam resistance of PBP2a from methicillin-resistant Staphylococcus aureus. Lim D; Strynadka NC Nat Struct Biol; 2002 Nov; 9(11):870-6. PubMed ID: 12389036 [TBL] [Abstract][Full Text] [Related]
16. Review of the in-vitro evaluation of FCE 22101. Wise R; Ballard RC J Antimicrob Chemother; 1989 Mar; 23 Suppl C():7-16. PubMed ID: 2659572 [TBL] [Abstract][Full Text] [Related]
17. Discovery of MC-02,331, a new cephalosporin exhibiting potent activity against methicillin-resistant Staphylococcus aureus. Hecker SJ; Cho IS; Glinka TW; Zhang ZJ; Price ME; Lee VJ; Christensen BG; Boggs A; Chamberland S; Malouin F; Parr TR; Annamalai T; Blais J; Bond EL; Case L; Chan C; Crase J; Frith R; Griffith D; Harford L; Liu N; Ludwikow M; Mathias K; Rea D; Williams R J Antibiot (Tokyo); 1998 Aug; 51(8):722-34. PubMed ID: 9766464 [TBL] [Abstract][Full Text] [Related]
18. [Bases of the antibacterial effect of beta lactam antibiotics]. Hof H Immun Infekt; 1991 Dec; 19(6):175-8. PubMed ID: 1802833 [TBL] [Abstract][Full Text] [Related]
19. Interaction of beta-lactam antibiotics with the penicillin-binding proteins of penicillin-resistant Streptococcus pneumoniae. Ikeda F; Yokota Y; Ikemoto A; Teratani N; Shimomura K; Kanno H Chemotherapy; 1995; 41(3):159-64. PubMed ID: 7656660 [TBL] [Abstract][Full Text] [Related]
20. In-vitro and in-vivo antibacterial activity of imipenem against clinical isolates of bacteria. Mitsuhashi S J Antimicrob Chemother; 1983 Dec; 12 Suppl D():53-64. PubMed ID: 6607914 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]